JLHLJupiter Life Line

₹1553.9-0.98%

Market Cap

₹10,168.31 Cr

Stock P/E

52.76

ROCE

18.82%

ROE

15.32%

Book Value

₹213.54

Financials

YoY Net Sales

EPS Growth

Operating Margin

You might have missed

No Recent News

No recent news available for this stock.

Shareholding

Holdings

Distribution

Promoter

Foreign Investors

Domestic Investors

Public

From Last Concall

POSITIVES

•
Strong top-line and margin momentum in Q1: revenue and EBITDA growth with healthy margins.
•
Renewable energy investments add to long-term cost efficiency and sustainability.

NEGATIVES

•
Near-term earnings headwinds from higher depreciation and finance costs, implying wider PAT-EBITDA gap.
•
Dombivli greenfield expansion is likely to depress margins in the near term due to negative EBITDA in Year 1.

Peers Summary

Sector Leader

Jupiter Life Line Hospitals Ltd. stands out among its peers with strong profitability metrics and solid growth figures, making it a compelling investment option in the healthcare sector. While some competitors show promising growth, they struggle with high valuations or profitability issues, positioning Jupiter as a potential leader in the hospital services industry.

Key Points

• Jupiter Life Line Hospitals has the highest EPS growth and ROE among peers.
• Aster DM Healthcare is the most undervalued based on PE and PBV ratios.
• Fortis Healthcare is the most financially stressed with extremely high PE and low profitability.

Top Performers

Jupiter Life Line Hospitals Ltd.

Strong EPS growth (29.33) and highest ROE (23.02) with zero debt.

Global Health Ltd.

High revenue growth (21.56% YoY) and good profitability metrics.

Narayana Hrudayalaya Ltd.

Solid ROE (24.27) and good EPS growth (38.66) with manageable debt levels.

Explore

Watchlists

Command Palette